Accumulation of S-adenosylhomocysteine (AdoHcy), the homocysteine (Hcy) precursor and a potent methyltransferase inhibitor, may mediate the neurological and vascular complications associated with elevated Hcy. Protein arginine methylation is a crucial post-translational modification and generates monomethylarginine (MMA) and dimethylarginine (asymmetric, ADMA, and symmetric, SDMA) residues. We aimed at determining whether protein arginine methylation status is disturbed in an animal model of diet-induced hyperhomocysteinemia (HHcy). HHcy was achieved by dietary manipulation of Wistar rats: methionine-enrichment (HM), B vitamins deficiency (LV), or both (HMLV). Total Hcy, S-adenosylmethionine (AdoMet), AdoHcy, MMA, ADMA and SDMA concentrations in plasma or tissues (heart, brain and liver) were determined by adequate high-performance liquid chromatography or liquid chromatography-electrospray ionization-tandem mass spectrometry methods. Moreover, in tissues from the HMLV group, histone arginine asymmetric dimethylation was evaluated by Western blotting, and the histone methylation marks H3R17me2a, H3R8me2a and H4R3me2a were studied. HHcy was induced by all special diets, with elevation of AdoHcy concentrations in liver (LV and HMLV) and heart (HMLV) (all versus control). Plasma ADMA levels were lower in all hyperhomocysteinemic animals. Protein-incorporated ADMA levels were decreased in brain and in heart (both for the LV and HMLV groups). Moreover, in brain of animals exposed to the HMLV diet, the H3R8me2a mark was profoundly decreased. In conclusion, our results show that diet-induced Hcy elevation disturbs global protein arginine methylation in a tissue-specific manner and affects histone arginine methylation in brain. Future research is warranted to disclose the functional implications of the global protein and histone arginine hypomethylation triggered by Hcy elevation.
Introduction
Elevation of total homocysteine (tHcy) in plasma, or hyperhomocysteinemia (HHcy), has been extensively associated with cardiovascular and neurological diseases [1] . Nevertheless, the underlying basis of these associations remains largely unknown and may involve several mechanisms. It has been hypothesized that homocysteine (Hcy) elevation disturbs the methylation capacity of the cell due to accumulation of its precursor S-adenosylhomocysteine (AdoHcy). AdoHcy is a competitive inhibitor of most methyltransferases that use AdoMet and, for this reason, a decreased AdoMet/AdoHcy ratio often indicates a reduced cellular methylation capacity [2] . Hcy is formed from methionine ( Fig. 1) , which is first activated by condensation with ATP to form S-adenosylmethionine (AdoMet), the methyl group donor for a wide variety of cellular methylation reactions. Upon transfer of the methyl group, AdoMet is converted to AdoHcy, which is hydrolyzed by AdoHcy hydrolase to adenosine and Hcy [1] . Importantly, this reaction is reversible and AdoHcy synthesis is thermodynamically favored over its hydrolysis, but due to efficient removal of the products, the reaction proceeds in the hydrolysis reaction [3] . Genetic defects in enzymes involved in the catabolism of Hcy, or deficiencies in cofactors required for those enzymes, hamper Hcy clearance and lead to AdoHcy accumulation, creating a cellular hypomethylating environment [4] . Several lines of evidence have shown that DNA is a target for the hypomethylating effect of AdoHcy accumulation in the context of HHcy. It has been observed that, in humans, plasma tHcy concentration correlates positively with AdoHcy level and negatively with lymphocyte global DNA methylation [5, 6] . Furthermore, mice deficient in methylenetetrahydrofolate reductase (MTHFR), an enzyme crucial for the folate-dependent remethylation of Hcy to methionine, are hyperhomocysteinemic and exhibit global DNA hypomethylation, decreased AdoMet levels and elevated AdoHcy levels, in several tissues [7] . Similarly, mice lacking activity of cystathionine beta-synthase (CBS), a key enzyme in the conversion of Hcy to cysteine through the transsulfuration pathway, have severely elevated plasma tHcy levels, high hepatic levels of AdoHcy and global DNA hypomethylation in liver [8] . However, the impact of Hcy elevation on methyl transfer reactions other than DNA methylation has been largely overlooked. Protein arginine methylation is an important and widespread post-translational modification that increases the structural diversity of proteins and modulates their function. Protein arginine methylation is catalyzed by protein arginine methyltransferases (PRMTs), which are divided into two major classes depending on the type of dimethylarginine they generate. Both type I and type II enzymes monomethylate the guanidinium nitrogen of arginine residues in proteins, forming [9] . PRMTs target numerous proteins involved in transcriptional regulation, signal transduction, RNA metabolism and DNA repair [9] . Particularly, histone targeting by PRMTs is an important epigenetic mechanism of gene expression regulation. The relationships between histone arginine methylation patterns and gene expression are intricate. Nevertheless, asymmetric dimethylation such as that of histone H3 at arginine residues 2 (H3R2), 17 (H3R17) and 26 (H3R26) is generally associated with transcriptionally permissive chromatin, while symmetric dimethylation (e.g. PRMT5-catalyzed symmetric dimethylation of H3R8 and H4R3) associates with heterochromatin formation and gene repression [10] . It is currently unknown whether Hcy elevation leads to inhibition of PRMTs activity via AdoHcy accumulation, thereby reducing histonic or non-histonic arginine methylation.
We have previously observed that AdoHcy accumulation in human endothelial cells induces hypomethylation of arginine residues in proteins to a greater extent than DNA hypomethylation [11] . This observation led us to hypothesize that protein arginine hypomethylation is a new player in the pathophysiology of HHcy. The present study was designed to disclose the impact of elevated Hcy on global protein and histone arginine methylation status in different tissues (liver, heart and brain) obtained from a murine model in which HHcy was induced by diets enriched in methionine, B vitamins deficiency and the combination of methionine enrichment with B vitamins deficiency.
Materials and methods

Animals, diets and preparation of tissue homogenates
The studies presented here were performed in adult female Wistar rats with a body weight of approximately 250 g (Iffa Credo, Brussels, Belgium), in accordance with local prescriptions and the NIH Guide for the Care and Use of Laboratory Animals. For 8 weeks, the animals were fed one of the following diets: standard rodent chow (n = 19) Fig. 1 . Schematic representation of the homocysteine metabolism. Methionine is converted to S-adenosylmethionine (AdoMet) by methionine adenosyltransferase (MAT). AdoMet serves as methyl group donor in a horde of methylation reactions in which it is converted to S-adenosylhomocysteine (AdoHcy). The latter may be subsequently hydrolyzed by S-adenosylhomocysteine hydrolase (SAHH) to homocysteine (Hcy) and adenosine. Under normal physiological conditions, homocysteine is readily exported or catabolized through the transsulfuration and remethylation pathways. Deficiencies in cofactors that are required for these pathways, namely B vitamins, prevent the biochemical transformation of Hcy and may induce AdoHcy accumulation, which may result in cellular hypomethylation. CBS = cystathionine beta-synthase. MS = methionine synthase. MTHFR = methylenetetrahydrofolate reductase. SHMT = serine hydroxymethyltransferase. BHMT = betaine-homocysteine S-methyltransferase.
(control); diet enriched in methionine (n = 8) (HM); diet deficient in B vitamins (folic acid, B 6 and B 12 ) (n = 8) (LV); diet enriched in methionine and deficient in B vitamins (folic acid, B 6 and B 12 ) (n = 8) (HMLV) ( Table 1) . Then the animals were anesthetized with thiobutabarbital (Inactin, RBI; 100 mg/kg IP) and blood was collected by cardiac puncture. Samples of liver, heart and brain were obtained and cut into small pieces using a surgical blade, weighed and stored at −80°C until use.
Tissue homogenate was prepared on ice in 0.1 N HCl (10 mL/g wet weight of tissue) with an OMNI-2000 homogenizer (Omni 2000, OMNI International, Waterbury, CT, USA). Immediately after homogenization, a part of the homogenate was processed for AdoMet and AdoHcy determination as described below. The remainder was aliquoted and stored at −80°C until further use. For protein concentration determination, an aliquot was thawed, centrifuged at 12,000 g at 4°C for 5 min to remove debris and the supernatant was analyzed with the Bicinchoninic Acid Protein Assay Kit (Pierce, Rockford, IL, USA), using bovine serum albumin as the standard.
AdoMet and AdoHcy in tissue homogenates
For quantification of AdoMet and AdoHcy, the homogenate was centrifuged at 12,000 g, at 4°C, for 5 min to remove debris and the supernatant was promptly 10-fold diluted in 0.1 N HCl on ice to a final volume of 250 μL, followed by addition of 156 μL of 10% (v/v) perchloric acid for deproteinization. After centrifugation for 10 min at 2000 g, at 4°C, the supernatant was subjected to a weak anion-exchange solid-phase extraction procedure using a Waters Oasis HLB 3 cc (30 mg) extraction column (Waters, Milford, MA, USA) and analyzed by stable-isotope dilution liquid chromatographytandem mass spectrometry, as previously described in detail [12] .
Plasma tHcy concentration
Total plasma homocysteine concentrations were measured with a high-performance liquid chromatography procedure with reverse phase separation and fluorescence detection, as described previously [13] .
Protein hydrolysis
After centrifugation of the homogenate for 5 min at 12,000 g at 4°C to remove debris, a 50 μL aliquot of the homogenate supernatant was mixed with an equal volume of 40% (w/v) trichloroacetic acid. After centrifugation at 4°C, 16,000 g, for 10 min, the supernatant was removed and the pellet was washed twice with 1 mL of ice-cold acetone and allowed to dry at room temperature. Protein hydrolysis was carried out at 110°C with 6 N HCl for about 20 h in capped glass vials. The hydrolysates were dried under a gentle stream of nitrogen gas and stored at − 20°C until use.
Levels of methylarginines in plasma and protein hydrolysates
Unmethylated L-arginine (Arg) and its methylated forms (MMA, ADMA and SDMA) in plasma and tissue protein hydrolysates were determined by high-performance liquid chromatography with fluorescence detection, as previously described [14, 15] . Briefly, after sample cleanup by cationic solid-phase extraction (MCX 1 cc cartridges, Waters Oasis, Milford, MA, USA), the analytes were derivatized with a reagent containing ortho-phthaldialdehyde (18.7 mM) and 3-mercaptopropionic acid (28.7 mM). Chromatographic separation of the fluorescent derivatives was performed on a Chromolith Performance RP-18e column (100 × 4.6 mm) protected by a matching guard cartridge (10 × 4.6 mm) from Merck (Darmstadt, Germany). Homoarginine was used as internal standard. The levels of MMA, ADMA and SDMA in tissue protein hydrolysates were expressed as fractions of total arginine (tArg) content.
Histone arginine methylation
The degree of asymmetric dimethylation of histone residues H4R3, H3R17 and H3R8 was analyzed by Western blotting. Histone proteins were extracted from tissues using the EpiSeeker Histone Extraction Kit (Abcam, Cambridge, UK) following the manufacturer's protocol, separated on 15% SDS-polyacrylamide gels and transferred onto Hybond-P poly(vinylidene difluoride) membranes (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK). The membranes were probed overnight at 4°C with primary antibodies diluted in 5% non-fat milk in TBST: mouse monoclonal anti-H4 (Abcam, Cambridge, UK) 1:1000; mouse monoclonal anti-H3 (Active Motif, Rixensart, Belgium) 1:2000; rabbit polyclonal anti-H4R3me2a (Active Motif, Rixensart, Belgium) 1:2000; rabbit polyclonal anti-H3R17me2a (Active Motif, Rixensart, Belgium) 1:1000; rabbit polyclonal antiH3R8me2a (Active Motif, Rixensart, Belgium) 1:3000. Secondary antibody incubation was performed for 2 h at room temperature with horse-radish peroxidase-conjugated anti-rabbit IgG (Cell Signaling, Danvers, MA, USA; 1:2000) or anti-mouse IgG (Jackson Immuno Research, Suffolk, UK; 1:4000). The chemiluminescence reaction was accomplished by incubating membranes with the developer solution (ECL + Plus Western blotting detection system; GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK) and signal was detected using a ChemiDoc System (BioRad, Hercules, CA, USA). The signal corresponding to each methylation mark was normalized with the one of the corresponding total histone.
Statistical analysis
Data in text and tables are presented as mean ± SD. Data in figures is represented by box-and-whiskers plots: each box is the interquartile range, the horizontal line bisecting the box is the median and whiskers are the minimum and maximum values. Differences between two independent groups were analyzed by the Mann-Whitney U test. The Spearman's test was used for correlation analysis. Statistical significance was accepted at P b 0.05. In the graphed and tabled data, ⁎ , ⁎⁎ , and ⁎⁎⁎ denote P values lower than 0.05, 0.01, and 0.001, respectively.
Results
Plasma tHcy level was 4.8 ± 0.9 μmol/L in rats fed the standard chow. Administration of the methionine-enriched diet (HM) increased tHcy levels to 22.7 ± 6.6 μmol/L and higher levels (34.8 ± 14.8 μmol/L) were found in rats maintained on the low B vitamins diet (LV). Hyperhomocysteinemia was even more pronounced (83.8 ±34.9 μmol/L) in rats fed the methionine-enriched diet deficient in B vitamins (HMLV). 3.1. Decreased cellular methylation capacity in liver and heart of hyperhomocysteinemic rats
In order to ascertain whether the diets affected tissue methylation capacity, we measured the levels of AdoMet and AdoHcy in liver, heart and brain. Dietary methionine enrichment alone did not affect AdoMet and AdoHcy levels. However, nutritional B vitamins deprivation, either alone or in combination with methionine enrichment, affected AdoMet and AdoHcy levels in a tissue-specific manner. Rats fed the LV diet had decreased (P b 0.01) AdoMet levels in liver (434.6 ± 87.1 nmol/g protein) and in heart (226.2 ± 18.0 nmol/g protein), compared with controls (569.6 ± 86.8 nmol/g protein in liver and 322.1 ± 105.7 nmol/g protein in heart). Dietary B vitamins deficiency in combination with methionine enrichment did not affect tissue AdoMet levels. Animals fed the LV diet had higher (P b 0.01) hepatic levels of AdoHcy (177.9 ± 15.0 nmol/g protein) than animals fed the standard chow (153.9 ± 15.5 nmol/g protein), but AdoHcy levels in other tissues were not affected. Rats fed the HMLV diet had increased levels of AdoHcy in liver (209.5 ± 18.9 nmol/g protein) and in heart (27.6 ± 10.0 nmol/g protein) when compared to controls (153.9 ± 15.5 nmol/g protein in liver and 9.2 ± 4.1 nmol/g protein in heart) (P b 0.001). AdoMet/AdoHcy ratios in the LV and HMLV diet groups were lower (P b 0.05) in liver (LV: 2.5 ± 0.6; HMLV: 2.7 ± 0.5) and heart (LV: 16.9 ± 7.2; HMLV: 14.2 ± 4.8), compared with controls (liver: 3.7 ± 0.6; heart: 35.3 ± 8.2). Therefore, dietary restriction of B vitamins in combination with methionine enrichment in this model may reduce cellular methylation capacity in liver and heart. No differences in AdoMet and AdoHcy levels were observed in brain.
Decreased levels of free ADMA in plasma of hyperhomocysteinemic rats
The HM, LV and HMLV diets resulted in significantly lower levels of free ADMA in plasma than the control diet ( Fig. 2A) . Free SDMA levels were lower (P b 0.001) in animals fed the HM diet (0.28 ± 0.02 μM) compared with controls (0.31 ± 0.04 μM). The levels of free MMA in plasma were below the limit of detection of the method. Free arginine concentration in plasma averaged 72.5 ±27.9 μM and was not affected by diet manipulation.
3.3. Disturbed protein arginine methylation status in heart and brain, but not in liver, of hyperhomocysteinemic rats
The levels of protein-incorporated MMA, ADMA and SDMA in tissue homogenates were regarded as indicators of protein arginine methylation status. The level of each methylarginine species was normalized to total arginine content (tArg), which was defined as the sum of unmethylated L-arginine and methylated arginine residues. Total protein-incorporated arginine level in all animals averaged 367 ± 38 nmol/mg protein in liver, 298 ± 24 nmol/mg protein in heart and 403 ± 35 nmol/mg protein in brain, and didn't change between diets.
The overall amount of protein-incorporated methylarginines accounted for approximately 0.2% of total arginine content in liver and heart and for 1.2% of total arginine content in brain. The average level of each methylarginine species in brain was at least 3-fold higher than in liver and heart (Table 2) .
Animals subjected to the methionine-enriched diet had in average 5.5% higher ADMA/tArg ratios in hepatic proteins and 20.7% higher MMA/tArg ratios in brain than animals fed the standard chow, suggesting that increased methionine availability enhances protein arginine methylation in these tissues. The degree of arginine methylation of the heart proteome was not affected by dietary methionine overloading (Table 2) . B vitamins deprivation decreased ADMA/tArg ratios in heart (7.5% lower) and brain (9.6% lower), but not in liver (Fig. 2B) . Interestingly, animals fed the LV diet had higher levels of protein-incorporated MMA (29.4% higher) and SDMA (14.7% higher) in brain than controls. Fig. 2 . Effect of diets on the levels of free ADMA in plasma (A) and protein-incorporated ADMA in liver, heart and brain (B). Rats were fed, for 8 weeks, with a standard rodent chow (control), a methionine-enriched diet (HM), a B vitamins deficient diet (LV) or a methionine-enriched diet deficient in B vitamins (HMLV). The levels of proteinincorporated ADMA were normalized to total arginine content and expressed as percentage of average level in control diet group. Each box represents the interquartile range, and the horizontal line bisecting it is the median and whiskers are the minimum and maximum values. ⁎ P b 0.05, ⁎⁎ P b 0.01 and ⁎⁎⁎ P b 0.001, diet versus control. In liver and heart, MMA/tArg and SDMA/tArg ratios were not affected by the LV diet (Table 2) . Dietary methionine enrichment in combination with B vitamins deprivation further decreased ADMA/tArg ratios in heart and liver (by 9.3% and 13.2%, respectively) (Fig. 2B) . In animals fed the HMLV diet, the average SDMA/tArg ratio in heart was 8.0% lower (borderline significance) than in controls (Table 2) .
In heart, ADMA/tArg and SDMA/tArg ratios correlated negatively with AdoHcy level and positively with AdoMet/AdoHcy ratio. In brain, both MMA/tArg and SDMA/tArg ratios were positively correlated with AdoMet and AdoHcy levels, but did not correlate with AdoMet/AdoHcy ratio. In liver and heart, MMA/tArg ratio correlated positively and strongly with both ADMA/tArg and SDMA/tArg ratios. However, in brain, MMA/tArg ratio was found to be negatively correlated with ADMA/tArg ratio and positively correlated with SDMA/ tArg ratio (Table 3) .
Decreased methylation of histone H3 at arginine 8 in brain of hyperhomocysteinemic rats
We have assessed the effect of diet-induced Hcy elevation on the methylation degree of a specific class of proteins, namely histones. The rationale for this choice was that histone arginine methylation has been very well studied, and it is an epigenetic mark crucially involved in the regulation of gene expression [10] . Since diet-induced HHcy affected the levels of protein-incorporated ADMA, and not those of SDMA, and based on the commercial availability of the antibodies, we have focused on the asymmetric dimethylation of 3 histone arginine residues, namely arginine 4 of histone H4 (H4R3me2a) and arginines 8 and 17 of histone H3 (H3R8me2a and H3R17me2a). Analysis was performed on whole preparations of heart, liver and brain from animals exposed to the control and HMLV diets. We selected the HMLV group because this diet induced the most significant decrease in tissue protein-incorporated ADMA levels (Fig. 2B) . The H4R3me2a and H3R17me2a methylation marks were not affected by the HMLV diet in all tissues (Fig. 3A) . H3R8me2a was not present in heart histone extracts and was not affected in liver. However, H3R8me2a in brain of animals exposed to the HMLV diet was approximately 70% lower than in controls (Fig. 3A and B) .
Discussion
Our study shows that in diet-induced HHcy global protein arginine methylation is disturbed in a tissue-specific manner. Specifically, the degree of asymmetric dimethylation in heart and brain is decreased, but not in liver. In brain, proteins display an increased content in MMA and SDMA residues. Moreover, we have identified a disturbed epigenetic mark on histone H3 in this tissue, suggesting for the first time that Hcy elevation affects histone arginine methylation patterns.
The present study was conducted to determine the impact of diet-induced Hcy elevation on global protein arginine hypomethylation in several tissues. The results are summarized in Table 4 . We have induced HHcy in rats by dietary methionine enrichment (HM), B vitamins deprivation (LV) or B vitamins deprivation combined with methionine enrichment (HMLV). Hepatic levels of AdoHcy in animals fed the LV and HMLV diets were higher when compared with controls. Only animals fed the HMLV diet displayed lower levels of AdoHcy in heart compared with controls. Accordingly, B vitamins deficiency, either with or without methionine enrichment, decreased AdoMet/AdoHcy ratios in both tissues. Thus, cellular methylation capacity in liver and heart may be decreased in HHcy due to B vitamins deficiency. Correlation analysis was performed by calculating the Spearman's rank correlation coefficients between the levels of AdoMet and AdoHcy, AdoMet/AdoHcy ratios and ratios of methylated arginine residues to total arginine content in liver, heart and brain. ⁎ P b 0.05. ⁎⁎ P b 0.01. ⁎⁎⁎ P b 0.001. Fig. 3 . Effect of diet-induced Hcy elevation on histone arginine methylation degree in liver, heart and brain. The degrees of asymmetric dimethylation of histone H4 at arginine 3 (H4R3me2a) and of histone H3 at arginines 17 (H3R8me2a) and 8 (H3R17me2a) in whole preparations of liver, heart and brain from animals fed either a standard rodent chow (control) or a methionine-enriched diet deficient in B vitamins (HMLV) were evaluated by Western blotting. (A) The signal corresponding to each methylation mark was normalized with that of the total histone (H3 or H4) and defined as methylation degree. Densitometry was performed on bands corresponding to 4 or 5 animals subjected to the HMLV diet and 4 or 5 controls. Each box represents the interquartile range, the horizontal line bisecting it is the median and whiskers are the minimum and maximum values. In order to explore the effect of diet-induced Hcy elevation on global protein arginine methylation status, we have determined the levels of free and protein-incorporated methylarginines in plasma samples and tissue homogenates, respectively. The plasma levels of free ADMA in hyperhomocysteinemic animals were markedly lower than in controls ( Fig. 2A) . Since ADMA inhibits the endothelial nitric oxide synthase (eNOS), an enzyme crucial for vascular function and homeostasis, several authors have suggested that ADMA elevation mediates the endothelial dysfunction observed in HHcy by reducing the production of nitric oxide (NO) [16] [17] [18] [19] [20] . However, a view gaining prominence is that they are either not related to each other or are both increased due to inadequate renal clearance [21] [22] [23] [24] . Importantly, we recently observed that CBS-deficient patients, presenting severe HHcy and high risk of vascular disease, have normal plasma levels of ADMA, supporting the notion that ADMA is not implicated in the vascular toxicity associated with HHcy [23] .
In line with the concept that Hcy elevation elicits cellular hypomethylation via AdoHcy build-up, we hypothesized that the decrease in plasma ADMA levels observed in our HHcy model was a reflection of protein hypomethylation. We measured the levels of methylated arginines in protein hydrolysates of the tissues as a more direct indication of protein arginine methylation degree. Several differences were observed concerning the effect of the different diets on tissue protein-incorporated MMA, ADMA and SDMA levels (Fig. 2B) . In liver, the HM diet elicited a slight increase in proteinincorporated ADMA levels (when compared to controls), but it did not affect SDMA levels. The LV and HMLV diets did not produce changes in the levels of protein-incorporated MMA, ADMA and SDMA in liver, although the levels of AdoHcy, as well as AdoMet/ AdoHcy ratios, were significantly affected. We conclude that protein arginine methylation status in liver is not disturbed in diet-induced Hcy elevation. Noteworthy, the liver expresses a set of unique enzymes involved in the one-carbon and Hcy metabolisms that may avert the effect of AdoHcy elevation on protein methylation. For instance, guanidinoacetate N-methyltransferase (GAMT) and phosphatidylethanolamine N-methyltransferase (PEMT), which are required for the production of creatine and phosphatidylcholine, respectively, consume the majority of methyl groups in liver [25] and both are inhibited by AdoHcy [26, 27] . Other extensive transmethylation reaction in liver is the one catalyzed by glycine N-methyltransferase (GNMT), which is highly expressed in liver and hardly in other tissues. The expression of GNMT is up-regulated in response to methionineinduced HHcy [28] , in light with the proposed role of GNMT as a methyl group buffering enzyme in the hepatic one-carbon metabolism.
In heart, methionine enrichment alone did not affect the levels of protein-incorporated MMA, ADMA and SDMA, suggesting that increased methionine availability does not cause protein hypermethylation, at least at arginine residues. It is important to note that MAT II, the predominant isoform in heart [29] , saturates at low concentrations of methionine. This mechanism may explain why methionine supplementation is ineffective in increasing AdoMet synthesis. We conclude that global protein arginine methylation status in heart is not modulated by dietary methionine intake. Interestingly, a decrease in the levels of proteinincorporated ADMA was observed in animals receiving the diet deficient in B vitamins. In addition, the levels of protein-incorporated ADMA, as well as those of SDMA, correlated negatively with AdoHcy level and positively with AdoMet/AdoHcy ratio. We have shown that, in heart, B vitamins deficiency elicits protein arginine hypomethylation due to AdoHcy elevation.
Protein arginine methylation status was also analyzed in brain homogenates. Interestingly, in controls, the levels of protein-incorporated MMA, ADMA and SDMA in brain were at least 3-fold higher than in liver and heart. Therefore, we conclude that the brain proteome is subject to methylation at arginine residues at a higher extent than the liver and heart proteomes. The levels of protein-incorporated ADMA in brain decreased in both B vitamins deficient diet groups (LV and HMLV) after 8 weeks of dietary manipulation. However, neither SDMA nor MMA mean levels decreased in these groups, but rather increased in the LV group (by 14.7% and 20.7%, respectively, compared with controls) suggesting increased symmetric dimethylation. We speculate that, in brain, asymmetric dimethylation is reduced, leading to accumulation of MMA, and the later is then used as substrate by type II PRMTs to form SDMA. Supporting this possibility, MMA/tArg ratio in brain correlated negatively with ADMA/tArg ratio and positively with SDMA/tArg ratio (Table 3) . Intriguingly, the levels of AdoMet and AdoHcy in brain were not significantly affected by diets, which would argue against brain specific PRMTs inhibition by AdoHcy. Noteworthy, the levels of AdoMet and AdoHcy in the tissues result from a fine-tuned balance between the rates of their formation and degradation, and the concentrations of AdoMet and AdoHcy do not necessarily reflect their turnovers. Therefore, the hypothesis that the B vitamins deficient diets affected the turnover of AdoMet and AdoHcy in brain, and thus their availability for transmethylation reactions, ought not to be excluded and should be addressed in detail in future investigations.
In an attempt to demonstrate a pathophysiological implication of the global protein arginine methylation disturbance observed in our HHcy model, we then focused on a specific class of proteins, namely histones. As previously referred, the levels of protein-incorporated ADMA were affected by diets, so we focused on asymmetric dimethylation of 3 arginine residues on histones H3 and H4 (H3R8, H3R17 and H4R3). In addition, we selected the HMLV group because this diet induced the most significant decrease in tissue protein-incorporated ADMA levels (Fig. 2B) . The degree of H4R3me2a and H3R17me2a methylation did not differ from that in controls in all tissues examined, suggesting that these epigenetic marks are not affected in HHcy. However, and interestingly, the amount of the H3R8me2a mark in brain from animals fed the HMLV diet was approximately 70% lower than in controls. Blythe and colleagues showed that in early embryos β-catenin, a protein with a key role in mammalian neural development, recruits PRMT2 to target promoters, thereby establishing the H3R8me2a mark. This event is necessary to define key organizer genes for later expression and to initiate the dorsal development program [30] . However, in our study, dietary treatment started at adulthood, which excludes any effect of H3R8 hypomethylation on brain formation. Until recently, histone arginine methylation was taken as a stable modification occurring mainly during cell and tissue differentiation and development. However, the discovery of histone demethylases has changed this concept, and histone arginine methylation is now accepted as a reversible modification and an important epigenetic mechanism of gene expression regulation [10] . In the context of our study, we have observed that Hcy elevation elicits H3R8me2a decrease in brain. The identification of genes whose expression is affected by reduction of the H3R8me2a mark may provide new insights on the molecular mechanisms underlying Hcy-related pathologies. The potential role of protein arginine methylation disturbance in the etiology of Hcy-related diseases has been largely neglected. Taken together, our results show an impairment of global protein arginine methylation in rats under HHcy induced by B vitamins deficiency, albeit in a tissue-specific manner. Namely, protein arginine methylation is disturbed in heart and in brain, but not in liver. We reason that the future identification of proteins that undergo differential methylation in heart and brain in the context of Hcy elevation may uncover novel pathophysiological mechanisms linking HHcy and neurological and vascular diseases. In addition, diet-induced Hcy elevation reduces the H3R8me2a mark in brain, warranting future investigation to disclose the consequences of this epigenetic derangement for brain homeostasis. 
